Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis

Amaka Awanye, Chun-Mien Chang, Jun X Wheeler, Hannah Chan, Leanne Marsay, Christina Dold, Christine S. Rollier, Louise E Bird, Joanne E. Nettleship, Raymond J. Owens, Andrew J. Pollard, Jeremy Derrick

Research output: Contribution to journalArticlepeer-review


Outer membrane vesicle (OMV)- based vaccines have been used to provide strain-specific protection against capsular group B Neisseria meningitidis infections, but the full breadth of the immune response against the components of the OMV has not been established. Sera from adults vaccinated with an OMV vaccine were used to screen 91 outer membrane proteins (OMPs) incorporated in an antigen microarray panel. Antigen-specific IgG levels were quantified pre-vaccination, and after 12 and 18 weeks. These results were compared with IgG levels from mice vaccinated with the same OMV vaccine. The repertoires of highly responding antigens in humans and mice overlapped, but were not identical. The highest responding antigens to human IgG comprised four integral OMPs (PorA, PorB, OpcA and PilQ), a protein which promotes the stability of PorA and PorB (RmpM) and two lipoproteins (BamC and GNA1162). These observations will assist in evaluating the role of minor antigen components within OMVs in providing protection against meningococcal infection. In addition, the relative dominance of responses to integral OMPs in humans emphasizes the importance of this subclass and points to the value of maintaining conformational epitopes from integral membrane proteins in vaccine formulations.
Original languageEnglish
JournalScientific Reports
Early online date2 May 2019
Publication statusPublished - 2019

Research Beacons, Institutes and Platforms

  • Lydia Becker Institute


Dive into the research topics of 'Immunogenicity profiling of protein antigens from capsular group B Neisseria meningitidis'. Together they form a unique fingerprint.

Cite this